Non-Hodgkin lymphoma

• Health & Medicine

CAR T cell immunotherapy now available through NHS Scotland for some adults with lymphoma

A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma. A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.

13 September 2019

• Health & Medicine

Targeted lymphoma drug gets green light for NHS in England

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England. People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

22 March 2019

• Health & Medicine

CAR T cell immunotherapy for lymphoma rejected in Scotland

Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS. Patients living with an aggressive form of lymphoma in Scotland will not get access to a new immunotherapy treatment after it was rejected for use on the NHS.

13 March 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

NHS England to fund engineered cell therapy for adults with aggressive lymphoma

A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today. A cancer immunotherapy will be offered on the NHS in England to some adults with aggressive non-Hodgkin lymphoma, NHS England announced today.

5 October 2018

• Health & Medicine

Engineered cell therapy given initial ‘no’ for aggressive adult lymphoma on NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England. A cancer immunotherapy has been provisionally rejected as a treatment for some adults with an aggressive type of non-Hodgkin lymphoma on the NHS in England.

19 September 2018

• Health & Medicine

Engineered cell therapy given initial ‘no’ for NHS in England

A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England. A cancer immunotherapy has been provisionally rejected as a treatment for some types of aggressive non-Hodgkin lymphoma on the NHS in England.

30 August 2018

Bioinvent’s BI-1206 antibody to enter collaborative phase I/II trial funded and conducted by Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma. Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma.

20 January 2015

• Health & Medicine

Organic food doesn’t lower overall cancer risk

Women who always or mostly eat organic foods are no less likely to develop cancer than women who eat a more conventional diet. Women who always or mostly eat organic foods are no less likely to develop cancer than women who eat a more conventional diet.

28 March 2014

• Science & Technology

Genetic profiling tracks progression from manageable blood cancer into deadly disease

Genetic profiling has uncovered how follicular lymphoma evolves from a manageable disease into an aggressive cancer. Genetic profiling has uncovered how follicular lymphoma evolves from a manageable disease into an aggressive cancer.

22 December 2013

• Health & Medicine

Non-Hodgkin lymphoma survival doubles since early 1970s

More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report from Cancer Research UK. More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report from Cancer Research UK.

23 May 2013

Deprived cancer patients face fatal health problems

Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows. Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows.

24 November 2010